[go: up one dir, main page]

GB9313649D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9313649D0
GB9313649D0 GB939313649A GB9313649A GB9313649D0 GB 9313649 D0 GB9313649 D0 GB 9313649D0 GB 939313649 A GB939313649 A GB 939313649A GB 9313649 A GB9313649 A GB 9313649A GB 9313649 D0 GB9313649 D0 GB 9313649D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939313649A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB939313649A priority Critical patent/GB9313649D0/en
Publication of GB9313649D0 publication Critical patent/GB9313649D0/en
Priority to ZA944671A priority patent/ZA944671B/en
Priority to AU73839/94A priority patent/AU7383994A/en
Priority to PCT/EP1994/002105 priority patent/WO1995001177A1/en
Priority to IL11016994A priority patent/IL110169A0/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB939313649A 1993-07-01 1993-07-01 Medicaments Pending GB9313649D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB939313649A GB9313649D0 (en) 1993-07-01 1993-07-01 Medicaments
ZA944671A ZA944671B (en) 1993-07-01 1994-06-29 Medicaments for the treatment of inflammatory diseases
AU73839/94A AU7383994A (en) 1993-07-01 1994-06-29 Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases
PCT/EP1994/002105 WO1995001177A1 (en) 1993-07-01 1994-06-29 Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases
IL11016994A IL110169A0 (en) 1993-07-01 1994-06-30 Pharmaceutical compositions comprising vapiprost

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939313649A GB9313649D0 (en) 1993-07-01 1993-07-01 Medicaments

Publications (1)

Publication Number Publication Date
GB9313649D0 true GB9313649D0 (en) 1993-08-18

Family

ID=10738145

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939313649A Pending GB9313649D0 (en) 1993-07-01 1993-07-01 Medicaments

Country Status (5)

Country Link
AU (1) AU7383994A (en)
GB (1) GB9313649D0 (en)
IL (1) IL110169A0 (en)
WO (1) WO1995001177A1 (en)
ZA (1) ZA944671B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5662682B2 (en) 2007-01-18 2015-02-04 エヴォルヴァ エスアー Substituted 1,3-dioxanes useful as PPAR modulators
BRPI0806686A2 (en) 2007-01-18 2014-11-04 Evolva Sa COMPOUNDS AND ITS USES, METHODS OF TREATMENT OR PREVENTION, PHARMACEUTICAL COMPOSITIONS AND CRYSTALLINE COMPOUND AND SOLVAT
WO2011057262A2 (en) * 2009-11-09 2011-05-12 Evolva Inc. Treatment of infections with tp receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation

Also Published As

Publication number Publication date
IL110169A0 (en) 1994-10-07
ZA944671B (en) 1995-01-16
AU7383994A (en) 1995-01-24
WO1995001177A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
GB9308430D0 (en) Medicaments
GB9202519D0 (en) Medicaments
AP9700951A0 (en) Medicaments
GB9201749D0 (en) Medicaments
ZA935522B (en) Medicaments
GB9315566D0 (en) Medicaments
GB9313574D0 (en) Medicaments
GB9314973D0 (en) Medicaments
AP9300592A0 (en) Medicaments
GB9202522D0 (en) Medicaments
GB9313649D0 (en) Medicaments
GB9206083D0 (en) Medicaments
GB9304021D0 (en) Medicaments
GB9304010D0 (en) Medicaments
GB9303188D0 (en) Medicaments
GB9325335D0 (en) Medicaments
GB9321194D0 (en) Medicaments
GB9207590D0 (en) Medicaments
GB9201404D0 (en) Medicaments
GB9205980D0 (en) Medicaments
GB9211802D0 (en) Medicaments
GB9204151D0 (en) Medicaments
GB9202523D0 (en) Medicaments
GB9211803D0 (en) Medicaments
GB9202521D0 (en) Medicaments